Sep 29

Scientific

SS 30 - Optimizing Therapy, Toxicity, and Supportive Care in Head & Neck Cancers

12:30pm - 01:45pm ET

Head and Neck Cancer

MODERATOR(S)

Philip Schaner, MD, PhD - Dartmouth-Hitchcock Medical Center

Yvonne Mowery, MD, PhD, BS - University of Pittsburgh Medical Center

Credits

AMA PRA Category 1 Credits:

1.00

Rate This Session

Presentations

12:30pm - 12:39pm ET

The HYPCON Trial 2: A Phase II Randomized Study Evaluating Hypofractionated vs. Conventional Adjuvant Concurrent Chemoradiation in Head and Neck Malignancies

Speaker: Aarcha Ramadas, MBBS - AIIMS New Delhi, New Delhi
12:39pm - 12:48pm ET

Light Against Pain: Photobiomodulation Against Mucositis Related Pain During Radiotherapy for Oral Cavity Cancer

Speaker: Siddhartha Nanda, MD - All India Institute of Medical Sciences, Raipur
12:48pm - 12:57pm ET

Comparison of Xerostomia in Head and Neck Cancer Patients Undergoing Radiation with and without Parotid Duct Sparing via MRI Sialography: A Randomised Control Study

Speaker: Pritanjali Singh, MBBS, DNB - All India Institute of Medical Sciences Patna, Patna
12:57pm - 01:06pm ET

First Report from the Headlight Trials: Postoperative Hypofractionated Proton Therapy for Head and Neck Cancers Unrelated to HPV

Speaker: Scott Lester, MD - Mayo Clinic Rochester, Rochester
01:06pm - 01:15pm ET

Baseline Carotid Artery Calcium Score Is Associated with High-Risk Carotid Ultrasound Findings In Head and Neck Cancer Survivors after Radiation Therapy: Secondary Analysis of a Prospective Study

Speaker: Jacob Johnson, - Wake Forest University School of Medicine, Winston-Salem
01:15pm - 01:24pm ET

Discussant

Speaker: Kenneth Shung Hu, MD, FASTRO - New York University, New York